L. De Kimpe

发表

Nanoparticles against Alzheimer's disease: PEG-PACA nanoparticles are able to link the aβ-peptide and influence its aggregation kinetic.

W. Scheper, M. Gobbi, P. Couvreur, 2010, Journal of controlled release : official journal of the Controlled Release Society.

New method based on capillary electrophoresis with laser-induced fluorescence detection (CE-LIF) to monitor interaction between nanoparticles and the amyloid-β peptide.

W. Scheper, M. Gobbi, P. Couvreur, 2010, Analytical chemistry.

Characterization of EVL-I as a protein kinase D substrate.

K. Janssens, J. Van Lint, J. Vandenheede, 2009, Cellular signalling.

Disturbed Ca2+ Homeostasis Increases Glutaminyl Cyclase Expression; Connecting Two Early Pathogenic Events in Alzheimer’s Disease In Vitro

W. Scheper, R. Zwart, J. Hoozemans, 2012, PloS one.

Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's disease.

Cristina Airoldi, Patrick Couvreur, Simona Mura, 2012, ACS nano.

Protein kinase D: a family affair

T. Seufferlein, J. Van Lint, J. Vandenheede, 2003, FEBS letters.

Protein Kinase D Controls Actin Polymerization and Cell Motility through Phosphorylation of Cortactin*

K. Pfizenmaier, J. Van Lint, A. Hausser, 2010, The Journal of Biological Chemistry.

From alpha to omega with Abeta: targeting the multiple molecular appearances of the pathogenic peptide in Alzheimer's disease.

W. Scheper, L. De Kimpe, 2010, Current medicinal chemistry.

Intracellular accumulation of aggregated pyroglutamate amyloid beta: convergence of aging and Aβ pathology at the lysosome

W. Scheper, R. Zwart, J. Hoozemans, 2012, AGE.

PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer's disease.

W. Scheper, M. Gobbi, P. Couvreur, 2012, ACS nano.

Removing protein aggregates: the role of proteolysis in neurodegeneration.

W. Scheper, J. Hoozemans, D. Nijholt, 2011, Current medicinal chemistry.

Highly sensitive single domain antibody-quantum dot conjugates for detection of HER2 biomarker in lung and breast cancer cells.

S. Maier, A. Prina‐Mello, Y. Volkov, 2014, ACS nano.

Characterization of cortactin as an in vivo protein kinase D substrate: interdependence of sites and potentiation by Src.

T. Seufferlein, K. Janssens, J. Van Lint, 2009, Cellular signalling.

Doxorubicin-induced activation of protein kinase D1 through caspase-mediated proteolytic cleavage: identification of two cleavage sites by microsequencing.

P. Vandenabeele, D. Vertommen, G. Kéri, 2004, Cellular signalling.

An enzyme-linked immunosorbent assay for protein kinase D activity using phosphorylation site-specific antibodies.

K. Janssens, J. Van Lint, E. Waelkens, 2007, Assay and drug development technologies.

Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's disease.

M. Masserini, W. Scheper, M. Gobbi, 2012, ACS nano.

Highly sensitive single domain antibody-quantum dot conjugates for detection of HER2 biomarker in lung and breast cancer cells.

S. Maier, A. Prina‐Mello, Y. Volkov, 2014, ACS nano.